期刊文献+

血管紧张素转化酶抑制剂加钙离子拮抗剂联合用药治疗模式对于轻、中度原发性高血压的临床疗效观察及其对血尿酸水平的影响 被引量:5

Clinical investigation of ACE inhibitor combined with calcium antagonist on the patients with mild to moderate essential hypertension and it's effect on the serum uric acid level
下载PDF
导出
摘要 目的:比较卡托普利与氨氯地平联合用药与氨氯地平单独使用对于轻、中度原发性高血压患者的血压的调控及其血尿酸水平的影响。方法:选取本院门诊轻、中度原发性高血压患者80例进行随机、双盲的临床研究,所有患者经过2周清洗期后随机分为两组,其中联合用药组40例,采用卡托普利25 mg/次,每天2次,加氨氯地平5 mg/d处理;钙拮抗剂组40例,采用氨氯地平5 mg/d处理,为期8周。对比观察治疗前后血压变化情况。采用全自动生化分析仪检测治疗前后患者空腹血尿酸的变化情况。结果:联合用药组治疗4周后,平均坐位舒张压由治疗前的(98±7)mm Hg(1 mm Hg=0.133 kPa)下降至(92±8)mm Hg;治疗8周后,平均坐位舒张压为(86±11)mm Hg,治疗后较治疗前显著降低(P<0.05)。钙拮抗剂组,治疗前平均坐位舒张压为(96±8)mm Hg,治疗4周后,平均坐位舒张压为(95±7)mm Hg,与治疗前比较无统计学差异(P>0.05);治疗8周后,平均坐位舒张压为(90±8)mm Hg,较治疗前显著降低(P<0.05)。治疗8周后,两组间平均坐位舒张压下降幅度比较,联合用药组降低更为显著(P<0.05)。联合治疗与钙拮抗剂都能降低患者的血尿酸水平,联合用药组降低程度明显高于钙拮抗剂组(P<0.05)。结论:早期联合用药治疗轻、中度高血压患者,能够很好地控制轻、中度高血压,同时能够更好地发挥对重要脏器的保护作用。 AIM: To compare the clinical effeet of combination of captopri with amlodipine and monotherapy of amlodipine, and the influ-ence on the serum uric acid level. METHODS: 80 patients with mild to moderate essential hy-pertension were selected and divided into two groups. 40 treated with amlodipine (tients of the patients of the study group were captopri (25mg/capsule, bid) and 5 mg, q. d.) for 8 weeks, 40 pa control group were treated with am-lodipin (5mg, q. d. ) for 8 weeks. The efficacy of both groups was evaluated by comparing the variance of blood pressure and serum uric acid. RESULTS: The blood pressure of the combined therapy was decreased from (98±7) mm Hg to (92±8) mm Hg after 4 weeks and to (86±11) mm Hg after 8 weeks, the difference is statisti- cally significant (P〈0.05). The blood pressure of the monotherapy group was (96±8) mm Hg, which is not statistically significant different from (95±7) mm Hg after 4 weeks. The blood pressure of the monotherapy group was (90±8) mmHg after 8 weeks, which is significantly dif-ferent from (96±8) mm Hg (P〈0.05). The decreased extent of the combined therapy group was significantly different from the monotherapy group. The serum uric acid of the two groups were decreased and the decreased extent of the combined therapy was significant than that of monotherapy group. CONCLUSION. The corn bined therapy for the mild to moderate essential hypertension is an effective strategy and can pro-tect the organ.
作者 伍艳
出处 《中国临床药理学与治疗学》 CAS CSCD 2011年第3期317-321,共5页 Chinese Journal of Clinical Pharmacology and Therapeutics
关键词 血管紧张素转化酶抑制剂 钙离子拮抗剂 高血压 临床疗效 血尿酸 ACE inhibitor Calcium antago-nist Hypertension Effect Serum uric acid
  • 相关文献

参考文献11

  • 1许林勇,张伟,杨天伦,孙振球.西尼地平胶囊治疗轻中度原发性高血压的有效性和安全性临床研究[J].中国临床药理学与治疗学,2010,15(5):555-560. 被引量:2
  • 2Barker DJ, Osmond C, Forsen TJ, et al. Maternal and social origins of hypertension [J]. Hypertension,2007,50(3) : 565-571.
  • 3Nuyt AM, Alexander BT. Developmental program ming and hypertension [J].Curr Opin Nephrol Hy pertens,2009,18(2) : 144--152.
  • 4Matsumura K, Ohtsubo T, Oniki H, et al. Genderrelated association of serum uric acid'and left ventricular hypertrophy in hypertension[J]. Circ J,2006,70(7), 885--888.
  • 5Perticone F, Maio R, Ruberto C, et al. Kidney function and risk factors for left ventricular hypertrophy in untreated uncomplicated essential hypertension [J].Am J Kidney Dis, 2008, 52 (1) : 74-84.
  • 6Wald DS, Law M, Morris JK, et al. Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials [J]. Am J Med,2009,122(3) : 290-300.
  • 7Morgan TO, Anderson AL, Maclnnis RJ. ACE in hibitors, beta-blockers, calcium blockers, and diu retics for the control of systolic hypertension [J]. Am J Hypertens,2001,14(3) : 241-247.
  • 8Oparil S, Yarows SA, Patel S. Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension., a randomized, doubleblind trial [J]. Lancet,2007,370(9583) :221--229.
  • 9Everett BM, Glynn RJ,.Danielson E, et al. Combi nation therapy versus monotherapy as initial treat ment for stage 2 hypertension: a prespecified sub group analysis of a community-based, randomized open-label trial [J]. Clin Ther, 2008,30 (4) : 661 - 672.
  • 10Forman JP, Choi H, Curhan GC. Plasma uric acid level and risk for incident hypertension among men [J].J Am Soc Nephrol,2007,18(1) : 287-292.

二级参考文献3

共引文献1

同被引文献88

引证文献5

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部